Skip to content

Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection

Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00688389
Enrollment
700
Registered
2008-06-02
Start date
2007-07-31
Completion date
2020-12-31
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue Fever

Keywords

Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,, decoy receptor 3 (DcR3), Toll-like receptors(TLRs),, (Nod)-like receptors (NLRs)

Brief summary

The study will collect the blood samples from 350 healthy persons and 350 persons infected with dengue fever.

Detailed description

Research has showed that CLEC5A interacts with dengue virion directly, and is responsible for dengue virus (DV)-induced DAP12 phosphorylation. Data suggests that CLEC5A is a potential therapeutic target for dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). This project will study the genes of CLEC5A, Mannose receptor, DC-SIGN, NALP, decoy receptor 3 (DcR3), Toll-like receptors(TLRs), and (Nod)-like receptors (NLRs) for both DF and DHF groups. In addition, serum level of decoy receptor 3 (DcR3) will be tested. The study will collect the blood samples from 350 healthy persons and 350 persons infected with dengue fever.

Interventions

OTHERcase/control

case: infected dengue fever people control:healthy people

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of Dengue fever

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
檢查肝臟、腎臟及其他生化功能,並分析宿主免疫調控及血小板變化機致2007/7/1抽血20 c.c 檢查肝臟、腎臟及其他生化功能,並分析宿主免疫調控及血小板變化機致

Countries

Taiwan

Contacts

Primary ContactJih-Jin Tsai, MD
jijits@cc.kmu.edu.tw886-7-312-1101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026